1. Home
  2. AAPG vs PJT Comparison

AAPG vs PJT Comparison

Compare AAPG & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • PJT
  • Stock Information
  • Founded
  • AAPG 2009
  • PJT 2014
  • Country
  • AAPG China
  • PJT United States
  • Employees
  • AAPG N/A
  • PJT N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • PJT Investment Managers
  • Sector
  • AAPG Health Care
  • PJT Finance
  • Exchange
  • AAPG Nasdaq
  • PJT Nasdaq
  • Market Cap
  • AAPG 3.6B
  • PJT 3.9B
  • IPO Year
  • AAPG 2025
  • PJT N/A
  • Fundamental
  • Price
  • AAPG $33.87
  • PJT $166.26
  • Analyst Decision
  • AAPG Strong Buy
  • PJT Hold
  • Analyst Count
  • AAPG 3
  • PJT 3
  • Target Price
  • AAPG $49.00
  • PJT $193.50
  • AVG Volume (30 Days)
  • AAPG 8.0K
  • PJT 237.3K
  • Earning Date
  • AAPG 11-19-2025
  • PJT 11-04-2025
  • Dividend Yield
  • AAPG N/A
  • PJT 0.60%
  • EPS Growth
  • AAPG N/A
  • PJT 72.84
  • EPS
  • AAPG N/A
  • PJT 6.53
  • Revenue
  • AAPG $54,524,554.00
  • PJT $1,657,789,000.00
  • Revenue This Year
  • AAPG N/A
  • PJT $11.42
  • Revenue Next Year
  • AAPG $368.64
  • PJT $12.18
  • P/E Ratio
  • AAPG N/A
  • PJT $25.55
  • Revenue Growth
  • AAPG N/A
  • PJT 23.30
  • 52 Week Low
  • AAPG $16.50
  • PJT $119.76
  • 52 Week High
  • AAPG $48.45
  • PJT $190.28
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • PJT 41.54
  • Support Level
  • AAPG $30.93
  • PJT $166.52
  • Resistance Level
  • AAPG $34.31
  • PJT $172.97
  • Average True Range (ATR)
  • AAPG 0.81
  • PJT 6.03
  • MACD
  • AAPG 0.26
  • PJT -0.04
  • Stochastic Oscillator
  • AAPG 85.99
  • PJT 29.95

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

Share on Social Networks: